chrX-135965109-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_173470.3(MMGT1):c.311C>T(p.Ser104Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000179 in 1,205,221 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 72 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_173470.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MMGT1 | ENST00000305963.3 | c.311C>T | p.Ser104Leu | missense_variant | 4/4 | 1 | NM_173470.3 | ENSP00000306220.2 | ||
MMGT1 | ENST00000679621.1 | c.311C>T | p.Ser104Leu | missense_variant | 5/5 | ENSP00000505226.1 | ||||
MMGT1 | ENST00000680510 | c.*108C>T | 3_prime_UTR_variant | 3/3 | ENSP00000505521.1 | |||||
MMGT1 | ENST00000681201 | c.*66C>T | 3_prime_UTR_variant | 3/3 | ENSP00000506673.1 |
Frequencies
GnomAD3 genomes AF: 0.0000897 AC: 10AN: 111529Hom.: 0 Cov.: 23 AF XY: 0.0000890 AC XY: 3AN XY: 33709
GnomAD3 exomes AF: 0.000115 AC: 21AN: 182577Hom.: 0 AF XY: 0.000134 AC XY: 9AN XY: 67359
GnomAD4 exome AF: 0.000188 AC: 206AN: 1093692Hom.: 0 Cov.: 28 AF XY: 0.000192 AC XY: 69AN XY: 359146
GnomAD4 genome AF: 0.0000897 AC: 10AN: 111529Hom.: 0 Cov.: 23 AF XY: 0.0000890 AC XY: 3AN XY: 33709
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 25, 2024 | The c.311C>T (p.S104L) alteration is located in exon 4 (coding exon 4) of the MMGT1 gene. This alteration results from a C to T substitution at nucleotide position 311, causing the serine (S) at amino acid position 104 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at